Townsquare Capital LLC Ligand Pharmaceuticals Inc Transaction History

Townsquare Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$74.52 - $117.06 $320,361 - $503,240	-4,299 Closed	0 $0
Q1 2022 Apr 28, 2022	BUY	$94.99 - $151.56 $65,733 - $104,879	692 Added 19.18%	4,299 $484,000
Q4 2021 Feb 11, 2022	BUY	$127.69 - $165.85 $254,358 - $330,373	1,992 Added 123.34%	3,607 $557,000
Q3 2021 Nov 15, 2021	BUY	$102.33 - $144.73 $165,262 - $233,738	1,615 New	1,615 $225,000

234

16.5M

77.9K

25K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.42B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Townsquare Capital LLC with notifications on news.